Bellvitge University Hospital

What Bellvitge University Hospital does

Bellvitge University Hospital (HUB, legal name Hospital Universitari de Bellvitge) is a large public tertiary university hospital located in L'Hospitalet de Llobregat, Catalonia, Spain, founded in 1972 and operated by the Institut Català de la Salut (ICS) under the Generalitat de Catalunya. It serves as the primary healthcare facility for the local population of L'Hospitalet and Prat de Llobregat, and functions as a high-complexity referral center for approximately 2 million people across southern Catalonia. As a teaching hospital it is affiliated with the University of Barcelona's Faculty of Medicine and Health Sciences (Bellvitge Campus) and runs a residency program with 110 positions (2026 call).

The hospital operates an extensive clinical technology stack: three Da Vinci robotic surgery systems and a Symani supermicrosurgery robot (six surgical robots total as of June 2026), the first PET/MRI in the Catalan public healthcare network (operational since November 2022, funded by Fundació Privada Daniel Bravo Andreu), a femtosecond laser for ophthalmic surgery (first in Catalonia's public network), and AI diagnostic tools including SEPI-IA for interstitial lung disease progression (developed with GMV and Tecnalia via €5M Next Generation EU funding, delivered March 2026) and MAP-AD (CE-marked blood biomarker for Alzheimer's progression, developed with ADmit Therapeutics). Research is conducted through the Carlos III-accredited IDIBELL biomedical research institute, and clinical sample management is supported by the ISO 9001:2015-certified Biobanc HUB-ICO-IDIBELL.

The business model is publicly funded through the Catalan Health Service under universal coverage, with no direct patient billing for covered services. Revenue is derived from public healthcare allocations, supplemented by limited fee-based services through the International Travel Health Center. Operations are supported by 5,628 professionals handling approximately 6,589 patients per day, 43,822 annual surgical interventions, 216,252 annual emergency attendances, 485,000 annual outpatient visits, and roughly 37,000 annual hospital discharges. The hospital participates in the BioCluster d'Innovació i Salut initiative, which projects 30,000 direct jobs and €4,400M in economic impact for the Barcelona metropolitan area.

Name

Bellvitge University Hospital

Legal name

Hospital Universitari de Bellvitge

Website

https://bellvitgehospital.cat

Company type

Private

Founded year

1972

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Bellvitge University Hospital is a public tertiary referral hospital in Catalonia, Spain, serving 2 million people across southern Catalonia with 5,628 professionals. It specializes in robotic surgery, organ transplantation, oncology, and AI-assisted diagnostics within the Catalan public healthcare system.

Ownership category

akta.pro rank

Product category

Public Tertiary Hospital Services

NAICS

General Medical and Surgical Hospitals (6221), General Medical and Surgical Hospitals (62211), General Medical and Surgical Hospitals (622110), Hospitals (622), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060), Services-Health Services (8000)

akta.pro primary industry

Community & Regional General Hospitals (HLAFAAAB)

akta.pro secondary industry

Transplant Specialty Hospitals (HLAFAHAE)

Keywords

• Tertiary hospital services
• Organ transplantation
• Robotic surgery
• Oncology treatment
• Medical diagnostics imaging

Headquarters

HQ city

Hospitalet De Llobregat

HQ country

Spain

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Public Healthcare Services: Bellvitge University Hospital operates as a public institution within the Catalan Health Service (Servei Català de la Salut). Services are funded through public taxation and universal healthcare coverage. No direct patient billing for covered services.
2. International Travel Health Services: The International Travel Health Center provides vaccination and health advisory services that may involve fees not covered by standard public healthcare, particularly for travel-specific vaccinations and certificates.

Go-to-market motion2 records

Distribution channels7 records

Marketing channels13 records

Core offering

Bellvitge University Hospital is a public tertiary university hospital that delivers comprehensive high-complexity medical and surgical services to the Catalan public health system, including advanced organ transplantation, robotic surgery, oncological surgery, neurological care, and AI-assisted diagnostics. Operated within the Institut Català de la Salut network, it serves as the reference center for maximum complexity cases for a population of 2 million in southern Catalonia while also providing proximity healthcare to the local citizens of L'Hospitalet and El Prat de Llobregat.

Product overview

Bellvitge University Hospital operates as a comprehensive healthcare institution offering a portfolio of clinical services, advanced medical technology, and AI-enabled diagnostic tools. The core offerings include robotic surgery programs using Da Vinci and Symani systems, a PET/MRI High Precision Diagnostic Center, and specialized services in organ transplantation, oncology, and neurology. The hospital's AI portfolio includes SEPI-IA for lung disease prediction and MAP-AD for Alzheimer's progression assessment. Supporting infrastructure includes SimHUB simulation center for professional training and the Biobanc HUB-ICO-IDIBELL for biomedical research sample management.

Differentiator

Problem solved

Functional benefit

Brands

• El Meu HUB: Mobile application for patients to manage appointments, access medical records, and interact with the hospital
• El Meu Quiròfan
• Veus de Bellvitge
• Aula de Salut
• Fes Salut
• Centre d'Alta Precisió Diagnòstica
• SimHUB
• Biobanc HUB-ICO-IDIBELL

Products and services

• Robotic Surgery Program (Da Vinci) Advanced minimally invasive robotic surgery program using Da Vinci systems spanning gynecology, urology, general surgery, maxillofacial surgery, and otorhinolaryngology, delivered to public healthcare patients in Catalonia.
• Symani Microsurgery Robot Service Microsurgery and supermicrosurgery service using the Symani surgical robot for millimeter-precision procedures on blood vessels, nerves, and lymphatic ducts supporting complex reconstructions and oncological sequelae treatment.
• PET/RM High Precision Diagnostic Center (Centre d'Alta Precisió Diagnòstica) High-precision diagnostic imaging service combining positron emission tomography and magnetic resonance, integrating anatomical, functional, and molecular information for early cancer detection with 60% reduced radiation versus PET/CT.
• SEPI-IA AI Diagnostic Tool Pre-commercial AI diagnostic tool that analyzes high-resolution CT scans to detect lesions invisible to the human eye and simulate interstitial lung disease progression at one, two, and three years, supporting early detection before irreversible lung damage.
• MAP-AD Blood Test CE-marked blood biomarker test predicting progression from mild cognitive impairment to Alzheimer's dementia, available for clinical use across the European Union.
• Femtosecond Laser Ophthalmology Femtosecond laser surgery service for cataract surgery with enhanced safety and efficiency, plus complex corneal surgery including lamellar corneal transplants.
• Organ Transplantation Service Solid organ transplantation service for adult liver, kidney, heart and tissue transplants, with a pioneering history beginning with Spain's first liver transplant in 1984 and using the VitaSmart HOPE perfusion system for marginal donor livers.
• Comprehensive Cancer Care (Oncology) Reference-center oncological service for high-complexity cancers including sarcomas, germ cell tumors, neuroendocrine tumors, neuro-oncological tumors, rare tumors, and metastatic melanoma, coordinated with ICO through Functional Units.
• SimHUB Advanced Medical-Surgical Simulation Center Advanced medical-surgical simulation training service for healthcare professionals enabling practice of clinical processes and high-complexity procedures in a risk-free simulated environment.
• Biobanc HUB-ICO-IDIBELL Research Biobank Biomedical research biobank providing collection, storage and management of biological samples for clinical and translational research across the Bellvitge Biomedical Campus.
• International Travel Health Center (Centre de Vacunació Internacional) Pre-travel vaccination and health advisory service providing vaccinations, official health certificates, and travel health guidance for individuals traveling to countries with health risks.
• Emergency Department Service 24/7 emergency care service covering all specialties except pediatrics and obstetrics, organized by triage urgency level and coordinated with regional emergency medical systems.
• Home Hospitalization Unit At-home acute care service providing hospitalization-level care to patients in their own homes across L'Hospitalet and Prat de Llobregat, reducing inpatient stays.

Quantifiable outcome

• Reduced 90-day mortality with HOPE perfusion system for liver transplants
• +3 more outcomes

Named customers3 records

Segments6 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability4 records

Feature6 records

Partnerships

Nine partnerships are on record, tiered minor and core.

• Cleveland Clinic FoundationminorStrategic or Co-development Partner · 11 May 2026Collaborating institution in clinical research demonstrating VitaSmart HOPE system effectiveness for marginal donor liver preservation. Studies from both Spanish transplant centers and Cleveland Clinic validated improved organ utilization and reduced 90-day mortality.
• GMVcoreTechnology or Integration · 25 March 2026Technology firm that developed the SEPI-IA AI prototype through the CDTI's Pre-Commercial Public Procurement mechanism. System analyzes high-resolution CT scans using AI to detect and quantify lesions.
• TecnaliacoreTechnology or Integration · 25 March 2026Technology firm that developed the SEPI-IA AI prototype through the CDTI's Pre-Commercial Public Procurement mechanism. Collaborated with GMV in the 5 million euro Next Generation EU funded project.
• ADmit TherapeuticscoreStrategic or Co-development Partner · 19 September 2025Biotechnology company that developed MAP-AD, a blood test for predicting progression from mild cognitive impairment to Alzheimer's dementia. Validation supported by IDIBELL and Bellvitge University Hospital. Test received CE marking for clinical use across the EU.
• Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)coreStrategic or Co-development PartnerResearch conducted within IDIBELL, a leading biomedical research institute accredited by Instituto de Salud Carlos III since 2009. HUB researchers make decisive contributions to IDIBELL's scientific production, particularly in clinical research. The institute provides infrastructure for clinical trials and research support.
• University of Barcelona - Faculty of Medicine and Health Sciences, Bellvitge CampuscoreStrategic or Co-development PartnerTeaching hospital linked to the Faculty of Medicine and Health Sciences, Bellvitge Campus. Provides training for medical degrees, nursing, dentistry, podiatry, and doctoral programs. Hosts international student exchanges including students from Universidad de Monterrey.
• Institut Català de la Salut (ICS)coreStrategic or Co-development PartnerBellvitge University Hospital belongs to Institut Català de la Salut, the public healthcare provider of Catalonia. ICS manages primary care centers and hospitals throughout the territory.
• Institut Català d'Oncologia (ICO)coreStrategic or Co-development PartnerOncology care is provided in coordination with ICO through Functional Units. Bellvitge Biomedical Campus includes Hospital Duran i Reynals (ICO). Joint services include medical oncology and radiotherapy with integrated care pathways.
• BioCluster Initiative PartnerscoreStrategic or Co-development PartnerL'Hospitalet BioCluster project is a partnership between multiple Catalan institutions (Bellvitge Hospital, ICO, IDIBELL, University of Barcelona, and others) aiming to establish Barcelona metropolitan area as a biomedical hub. Projects 30,000 direct jobs and 4,400 million euros economic impact, positioning Catalonia as biomedical capital of southern Europe.

Scale indicators17 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Hospital Clínic de Barcelona: Major Barcelona public university hospital affiliated with the University of Barcelona, providing tertiary care, research, and teaching comparable to Bellvitge. Strong overlap in transplant, oncology, and specialty medicine.
• Hospital Virgen del Rocío: Seville public university tertiary hospital, the largest hospital complex in Andalusia and a CSUR-designated reference center. Closely comparable to Bellvitge in regional tertiary referral role and teaching scale.
• Hospital General Universitario de Valencia: Public university tertiary hospital in Valencia serving as a regional referral center across multiple specialties. Comparable to Bellvitge in public financing model, university affiliation, and complex-care scope.
• Vall d'Hebron University Hospital: Catalonia's largest tertiary public university hospital and reference center for high-complexity care across multiple specialties, including transplants and oncology. Directly comparable to Bellvitge in scale, tertiary referral role, university affiliation, and CSUR designations.
• Hospital Universitario La Paz: Large Madrid-region public university tertiary hospital covering high-complexity care, transplants, and pediatric services. Comparable in scale, teaching mission, and tertiary referral posture to Bellvitge.
• Hospital Universitario 12 de Octubre: Madrid public university tertiary hospital with a comprehensive specialty portfolio and active research institute (i+12). Comparable to Bellvitge as a high-volume public tertiary center with transplant and oncology programs.
• Hospital de la Santa Creu i Sant Pau: Barcelona public university tertiary hospital with a parallel research institute (IIB Sant Pau). Comparable in academic medicine, CSUR designations, and tertiary referral role within the Catalan public system.
• Hospital Universitario Marqués de Valdecilla: Public university tertiary hospital in Santander, Spain, with strong transplant and research programs. Comparable to Bellvitge in CSUR designations, tertiary case mix, and teaching hospital structure.

Broad incumbents

• ICO - Institut Català d'Oncologia: Catalonia-wide public oncology network that co-delivers cancer services with Bellvitge through Functional Units and shares the Bellvitge Biomedical Campus. Comparable as a partner rather than a pure peer — overlapping in oncology but broader in mandate across Catalonia.

Others

• Cleveland Clinic: US-based academic medical center collaborating with Bellvitge on HOPE liver perfusion clinical research. Comparable as a high-complexity academic tertiary provider, but operating across a different geography and reimbursement system.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xtwitter.com/hbellvitge
• YouTubeyoutube.com/user/bellvitgehospital
• Facebookfacebook.com/hbellvitge
• LinkedInlinkedin.com/company/hospital-universitari-de-bellvitge
• Instagraminstagram.com/hbellvitge
• TikToktiktok.com/@hbellvitge

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bellvitge University Hospital